Alcon, Inc.

Alcon Laboratories, Inc.

Novartis Ag

Alcon Surgical, Inc.

Alcon Research, Ltd.

Alcon Universal Ltd.

Stephen J Van Noy

Mikhail Boukhny

Kyle Brown

Yinghui Wu

David Anthony Downer

Robert Hambleton

Douglas Brent Wensrich

Stephen John Collins

Anilbhai S Patel

Chi-Chun Tsai

Mutlu Karakelle

Lars D Jensen

Tu Cam Tran

John W Sheets, Jr

Xin Hong

James Yong Chon

Jian Liu

Son Trung Tran

Brett E Thomes

Michael J Simpson

Jonathan David McCann

Albert R Leboeuf

Sung Kyu Lee

John Evan Radle

Niranjana Nandakumar

David Eister

Thomas Carncross

Yi-Ren Woo

Ian Michael Marks

Xiaoxiao Zhang

Marshall Proulx

Michael John Simpson

Robert D Angelopoulos

Sushant P Muchhala

Yin Yang

James M Scott

Jihong Xie

Barry Stevens

Dengzhua (Dan) Yan

Brett E Thomas

Raymie H Lindsey

Dan Stanley

Marshall K Proulx

Dengzhu (dan) Yan

Dengzhu Yan

Apparatuses, systems, and methods for implanting an intraocular lens into an eye are described. For example, an intraocular lens injector may include a plunger and an injector body that includes an insertion depth guard and a nozzle extending therefrom. The insertion depth guard is disposed at a distal end of the injector body to limit a distance that the nozzle penetrates the eye. The intraocular lens injector may also include a biasing element configured to generate a counterforce to distal movement of the plunger through the injector rod. An example intraocular lens injector may include a biasing element to produce a counterforce that opposes advancement of the plunger through the injector body. The counterforce provides for a more continuous advancement of the plunger while reducing or substantially eliminating abrupt changes in the rate at which the plunger is advanced through the injector body.

Intraocular lens injector

Apparatuses, systems, and methods for implanting an intraocular lens into an eye are described. For example, an intraocular lens injector may include a passage formed in a distal end portion of the intraocular lens injector. The passage may define an interior surface, and a ramp may be formed on the interior surface so as to cause a leading haptic of an intraocular lens (IOL) being advanced through the passage to lift above a surface of an optic of the IOL to ensure proper folding of the IOL.

An ophthalmic device includes an optic including an optic axis and a closed-loop haptic structure coupled to the optic via a frame surrounding the optic, the closed-loop haptic structure including a closed loop extending from first and second attachment points to the frame. The closed loop includes a first hinge and a second hinge. The first hinge has a first section having a first component extending in a first angular direction, a second section having a second component extending in a second angular direction opposite to the first angular direction, and a first connecting section between the first section and the second section. The second hinge has a third section having a third component extending in the second angular direction, a fourth section having a fourth component extending in the first angular direction, the fourth section being connected to the second section to form the closed loop.

Intraocular lens having closed-loop haptic structures

An IOL system includes a capsular ring having a concave exterior surface extending around its circumference that is configured, upon insertion into a capsular bag of a patient's eye, to engage an equatorial region of the capsular bag. The concave exterior surface extends between an anterior surface and a posterior surface of the capsular ring. A first one or more flaps are arranged on the anterior surface such that at least a portion of each of the first one or more flaps, upon insertion into the capsular bag of a patient's eye, engages an anterior portion of the capsular bag. Similarly, a second one or more flaps are arranged on the posterior surface such that at least a portion of each of the second one or more flaps, upon insertion into a capsular bag of a patient's eye, engages a posterior portion of the capsular bag.

Intraocular lens having a capsular ring for inhibiting capsular opacification

An ophthalmic device includes an optic and a haptic structure coupled with the optic. The optic includes an optic axis. The haptic structure is coupled to the optic. The haptic structure retains the ophthalmic device within a capsular bag of a patient's eye. At least a portion of the haptic structure has a cross-section and a peripheral surface forming an outer periphery of a portion of the cross-section. At least a portion of the peripheral surface contacts the capsular bag and is smoothly curved.

Intraocular lens having a haptic structure with a streamlined cross-sectional geometry

An accommodating IOL includes a flexible optic membrane, a flexible skirt extending from an outer periphery of the flexible optic membrane and defining an outer periphery of the accommodating IOL, and a capsular contact ring configured to be positioned anterior to the flexible optic membrane and having a diameter less than a diameter at the outer periphery of the accommodating IOL. The accommodating IOL further includes a plurality of strut assemblies connecting the capsular contact ring and flexible skirt. When the capsular bag transitions from an accommodative state to a disaccomadative state, the capsular bag exerts a force on the capsular contact ring, at least a portion of that force being transferred to the flexible skirt by the plurality of strut assemblies. The transferred force causes a flattening of the flexible optic membrane in a manner that reduces the optical power of the accommodating IOL.

Accommodating intraocular lens

The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Ophthalmic device having therapeutic agent delivery capability and method of forming same

Aspheric optical lenses (e.g., intraocular lenses and contact lenses) are provided. The intraocular lens includes a body portion defining an anterior optical surface and an opposing posterior optical surface. The anterior optical surface includes a central region surrounded by a first outer region and a second outer region. The central region has a first asphericity profile. The first outer region has a second asphericity profile that is different than the first asphericity profile of the central region. The second outer region has a third asphericity profile that is different than the second asphericity profile of the first outer region. The overall asphericity profile of the optical lens provides different depths of focus for different pupil sizes. The result is an optical lens that provides increased depth of focus or pseudo-accommodation while maintaining desired optical power and performance.

Aspheric optical lenses and associated systems and methods

Growing community of inventors

Southlake, TX, United States of America

Stephen J Van Noy